A Chinese Prescription Chuanxiong Chatiao San for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abstract EN

Backgrounds.

Chuanxiong Chatiao san (CXCT) is a famous Chinese classical prescription.

It has a favorable effect in treating migraine.

It is reported that CXCT combined with Western conventional medicine (WCM) could increase the therapeutic efficacy on migraine.

The purpose of this paper is to systematically assess the clinical efficacy, safety, and some indexes of CXCT for migraine.

Methods.

PubMed, Embase Database, China National Knowledge Infrastructure (CNKI), Wanfang Database, the Cochrane Library, and the CBM were searched from January 2000 to February 2019.

We made a detailed record of outcome measurements.

Meta-analysis was performed using RevMan 5.3 software.

Results.

A total of 3307 patients were included in the 37 articles.

Meta-analysis showed that CXCT significantly increased the total efficiency rate (TER), compared with Western medicine treatment (WMC) (P < 0.00001).

When CXCT is combined with WMC, the result showed that P < 0.00001.

CXCT was significantly reduced the adverse events (AEs) compared with WMC (P < 0.00001).

The levels of VAS, number of migraine episodes (NE), and time of headache duration (TD) were significantly reduced (P < 0.00001).

Platelet function and blood rheology level were improved via a significantly decrease in 5-HT and β-EP (P < 0.00001).

Other indicators such as substance P, CGRP high-cut viscosity, low-cut viscosity, plasma viscosity, and fibrinogen were significantly reduced (P < 0.00001).

Conclusion.

Our findings provide evidence that CXCT and CXCT combined with WMC have higher efficacy in the treatment of migraine compared with WCM alone.

Methodological quality was generally low, so the conclusion of this paper has some limitations and it has to be carefully evaluated.